Acumen Welcomes New Members to its Advisory Board
Acumen Pharmaceuticals, Inc. has engaged three new members as part of its world-class Advisory Board.
Cynthia Lemere, Ph.D., Michael Weiner, M.D. and Reisa Sperling, M.D. will join the board alongside current advisors Colin Masters, M.D., Jeffrey Cummings, M.D., Sc.D., Jeffrey Sevigny, M.D., Stephen Salloway, M.D., and M.S., Steven DeKosky, M.D.
Acumen Chief Medical Officer Eric Siemers commented, “We are delighted to have Drs. Sperling, Lemere and Weiner join our Advisory Board. We believe the combined expertise of this group as an Alzheimer’s therapy development advisory board is unsurpassed.”